Seminars in Oncology
Volume 33, Supplement 2 , Pages 6-14, February 2006

Role of Gemcitabine in Breast Cancer Management: An Update

  • Baldeep Wirk
    • ,
  • Edith Perez

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Edith Perez, Division of Hematology-Oncology and Breast Cancer Program, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224

Division of Hematology-Oncology and Breast Cancer Program, Mayo Clinic, Jacksonville, FL

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding for this work was partially provided by the Breast Cancer Research Foundation.Dr Perez has received grant support from Bristol-Myers Squibb, Sanofi-Aventis, Elli Lilly and Company, Pfizer, Roche, and Genentech Inc.

PII: S0093-7754(05)00327-1

doi:10.1053/j.seminoncol.2005.07.028

Seminars in Oncology
Volume 33, Supplement 2 , Pages 6-14, February 2006

Article Tools